November 2023 in “Manuju” This paper discusses the complex relationship between polycystic ovary syndrome (PCOS) and hyperprolactinemia, noting a decrease in prolactin levels following bromocriptine treatment, but reports no new clinical findings.
December 2021 in “International Journal of Biomedicine” This review discusses the conflicting perspectives on the relationship between hyperprolactinemia and polycystic ovarian syndrome, emphasizing the need for further evaluation before diagnosing PCOS in the presence of hyperprolactinemia.
6 citations
,
October 2024 in “Reviews in Endocrine and Metabolic Disorders” In this review, researchers found that while hyper- and hypoprolactinemia in PCOS patients are linked to metabolic changes, intermediate prolactin levels might be protective, but more robust prospective studies and clinical trials are needed to confirm these findings and develop treatments.
February 2021 in “Facta Universitatis” This review discusses the current understanding of prolactin's role in female reproductive health and the diagnosis and treatment of hyperprolactinaemia but reports no new clinical findings.
September 2019 in “Mağallaẗ Tikrīt li-l-ʻulūm al-ṣirfaẗ” This study reported that women with polycystic ovary syndrome had significantly higher concentrations of oxytocin, testosterone, luteinizing hormone, prolactin, and follicle-stimulating hormone compared to healthy controls.